HWP
DGX icon

Highline Wealth Partners’s Quest Diagnostics DGX Stock Holding History

Highline Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18K Buy
+15
New +$2.94K ﹤0.01% 1000
2025
Q3 		– Sell
-4
Closed -$719 – 1094
2025
Q2 		$719 Hold
4
– – ﹤0.01% 761
2025
Q1 		$677 Buy
+4
New +$657 ﹤0.01% 801
2023
Q4 		– Sell
-58
Closed -$7.07K – 418
2023
Q3 		$7.07K Buy
+58
New +$7.73K ﹤0.01% 209

Other funds holding DGX

EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Highline Wealth Partners's DGX Position: Q2 2026 in Review

Highline Wealth Partners opened a new position in Quest Diagnostics (DGX) in Q2 2026: 15 shares worth $3.18K. The stake represents ﹤0.01% of the portfolio and ranks #1000 among its holdings. This is a return to the name: Highline Wealth Partners previously reported a position in DGX as recently as Q2 2025.

Highline Wealth Partners first reported a position in DGX in Q3 2023 and has held it in 4 quarters since. The position peaked at $7.07K in Q3 2023. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Highline Wealth Partners held 15 shares of Quest Diagnostics worth $3.18K as of Q2 2026.
  • Quest Diagnostics was a new Highline Wealth Partners position in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #1000 holding.
  • Highline Wealth Partners first reported a position in Quest Diagnostics in Q3 2023 and has held it in 4 quarters since.
  • Highline Wealth Partners's Quest Diagnostics position peaked at $7.07K in Q3 2023.
  • 152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.